Sign In
Buy NTRA
$318.35
-3.75 (-1.16%)
At Close: Aug 10, 2026
Natera Q1 Earnings Call Highlights
04:08pm, Friday, 08'th May 2026
Natera NASDAQ: NTRA reported first-quarter 2026 revenue of $697 million, up 39% year over year, as the company delivered more than 1 million total units in a single quarter for the first time. Chief E
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates
08:11pm, Thursday, 07'th May 2026
Natera (NTRA) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.5 per share a year ago.
Natera, Inc. (NTRA) Q1 2026 Earnings Call Transcript
08:11pm, Thursday, 07'th May 2026
Natera, Inc. (NTRA) Q1 2026 Earnings Call Transcript
Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
08:00pm, Thursday, 07'th May 2026
While the top- and bottom-line numbers for Natera (NTRA) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to
Natera Reports First Quarter 2026 Financial Results
04:05pm, Thursday, 07'th May 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the first quarter ended March 31, 2026. Rece
Prospera™ Evidence in Heart and Lung Transplantation Featured Across 17 Presentations at ISHLT
09:00am, Wednesday, 22'nd Apr 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a broad body of evidence supporting its Prospera test at the 2026
Merit Financial Group LLC Buys 4,610 Shares of Natera, Inc. $NTRA
06:00am, Monday, 20'th Apr 2026
Merit Financial Group LLC lifted its stake in Natera, Inc. (NASDAQ: NTRA) by 32.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC)
Natera, Inc. $NTRA Shares Sold by Mirae Asset Global Investments Co. Ltd.
05:18am, Monday, 20'th Apr 2026
Mirae Asset Global Investments Co. Ltd. reduced its stake in Natera, Inc. (NASDAQ: NTRA) by 21.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities a
Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst
02:30pm, Tuesday, 14'th Apr 2026
William Blair initiated coverage on Natera Inc. (NASDAQ:NTRA), highlighting the company's strong positioning in the emerging minimal residual disease (MRD) testing market and its broader growth outloo
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today highlighted Allogene Therapeutics' (NASDAQ: ALLO) interim futility analysis
Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents
06:00am, Thursday, 09'th Apr 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today provided an update on a recent decision issued by the United States District
3,949 Shares in Natera, Inc. $NTRA Acquired by Azzad Asset Management Inc. ADV
03:32am, Wednesday, 08'th Apr 2026
Azzad Asset Management Inc. ADV bought a new position in shares of Natera, Inc. (NASDAQ: NTRA) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund bought 3,94
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera's Oncology Platform
06:00am, Tuesday, 07'th Apr 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts, including two oral presentations, featuring data
Exchange Traded Concepts LLC Sells 2,945 Shares of Natera, Inc. $NTRA
03:52am, Saturday, 04'th Apr 2026
Exchange Traded Concepts LLC lessened its holdings in shares of Natera, Inc. (NASDAQ: NTRA) by 40.4% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 4,346 sh
Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery
12:48pm, Tuesday, 31'st Mar 2026
Natera stock is showing exceptional strength. What's fueling NTRA momentum?
